Company
United StatesPublic company, NYSE: CAHCardinal Health (NYSE: CAH), Omaha, NE – FDA Inspections
Inspection records and compliance data for Cardinal Health in Omaha, Nebraska. 1 FDA inspection on record, last inspected November 07, 2016. Publicly traded as NYSE: CAH.
Company Profile
This profile covers Cardinal Health based in Omaha, Nebraska, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected November 7, 2016.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 7, 2016 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 991452 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cardinal Health
Stock ticker
CAH
Exchange
NYSE
Share price
$269.30
Market cap
$62.4B
Price as of
November 6, 2026
FEI Number
3004251605
Address
4225 S 57th St, Omaha, Nebraska 68117, United States
Country
United States
ID: 88e33c50-348d-462b-886f-b9a01d68ebc5